Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Treatment of Cocaine Dependent ADHD Patients
NCT00015054Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Sep 1998
- Primary completion
- Oct 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylphenidate in cocaine-related disorders and attention deficit hyperactivity disorder (ADHD), sponsored by National Institute on Drug Abuse. Primary endpoints: Retention at 10 weeks, Cocaine use at 10 weeks and 1 more. Started Sep 1998; status: completed.
02
Drugs
methylphenidate
03
Conditions
cocaine-related disordersattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00015054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015054.